# R3 Vascular

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/r3-vascular

- Industry: Medical Devices & Equipment
- Headquarters: Mountain View, US
- Website: www.r3vascular.com
- Total disclosed funding: $105M
- Latest round: Series B (May 9, 2024)
- Investors on record: 4

## About

Founded in 2019 and based in California, US, R3 Vascular Inc. operates as a medical device company. The company was founded by its CTO, Kamal Ramzipoor. In May 2024, R3 Vascular Inc. raised USD 87 million in Series B funding led by Deerfield Management and 415 CAPITAL. The Series B funding values R3 Vascular Inc. at USD 126.09 million post-money. As of 2024, the company is led by its CEO, Chris Owens.

R3 Vascular manufactures and supplies medical devices, mainly bioresorbable vascular scaffolds, to treat peripheral arterial disease (PAD).

The company plans to use the funds raised in May 2024 to support its research and development initiatives and to accelerate its market presence.

## Funding rounds

- Series B, May 9, 2024, $87M — Deerfield Management, 415 CAPITAL
- Series A, Oct 8, 2020, $18M — Wexford Capital, HBM-MedFocus, 415 CAPITAL

## Investors

- Wexford Capital — Series A
- HBM-MedFocus — Series A
- 415 CAPITAL (https://capitalatlas.ai/funds/415-capital) — Series A, Series B
- Deerfield Management (https://capitalatlas.ai/funds/deerfield-management) — Series B